ACM
ANAC

Apex Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Apex Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$12.6M Buy
235,567
+16,079
+7% +$1.19M 0.28% 100
2015
Q4 		$24.8M Buy
219,488
+177,337
+421% +$19.5M 0.55% 66
2015
Q3 		$4.96M Buy
+42,151
New +$5.51M 0.11% 147

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Apex Capital Management's ANAC Position: Q1 2016 in Review

Apex Capital Management increased its ANACOR PHARMACEUTICALS INC COM (ANAC) stake by 7.3% in Q1 2016, buying an estimated $1.19M and bringing the position to 235,567 shares worth $12.6M. The position accounts for 0.28% of the portfolio, ranked #100.

Apex Capital Management first reported a position in ANAC in Q3 2015 and has held it in 3 quarters since. The position peaked at $24.8M in Q4 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

  • Apex Capital Management held 235,567 shares of ANACOR PHARMACEUTICALS INC COM worth $12.6M as of Q1 2016.
  • Apex Capital Management bought 16,079 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $1.19M.
  • ANACOR PHARMACEUTICALS INC COM made up 0.28% of Apex Capital Management's portfolio in Q1 2016, its #100 holding.
  • Apex Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and has held it in 3 quarters since.
  • Apex Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $24.8M in Q4 2015.
  • 199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.